Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...

The BREAKWATER study enrolled patients with newly diagnosed colon cancer that harbors a mutation called BRAF 600E that makes ...

REVEAL GENOMICS, S.L., a biotechnology company advancing precision oncology through biomarker innovation, today announced the ...

Seismic Therapeutic, Inc., the machine learning immunology company, today announced the appointment of Sophie Jones, M.D., as the company's Chief Financial Officer, effective June 18, 2025. In this ...

Onsite Parexel experts include recently appointed Chief Medical Officer and veteran oncologist Dr. Charlotte Moser, licensed medical oncologist and Global Therapeutic Area Head, Oncology, Dr. Gwyn ...

In such a war — elite vs. elite — there’s one obvious place to pitch the tents: a state where academia shapes the skyline and ...

Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, today announced promising results from its ...

As founder of HUYA Bioscience International, Lady Mireille Gillings built a pioneering model to accelerate the global development of novel biopharmaceutical therapies originating in China.

Personalized medicine—tailoring treatments to individual patients based on their genetic makeup, lifestyle, and environment—is ...

Twenty-eight students in the Jacobs School of Medicine and Biomedical Sciences were honored for outstanding achievements during the University at Buffalo’s 2025 Celebration of Student Academic ...

At the core of the new releases is Kuiper , Biognosys' novel search engine, powered by proprietary prediction models specifically optimized for unspecific searches. Kuiper delivers record-breaking ...